Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma

PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

January 31, 2001

Conditions
LeukemiaLymphoma
Interventions
BIOLOGICAL

denileukin diftitox

Trial Locations (6)

11042

Nassau Hematology/Oncology PC, Lake Success

29572

Coastal Cancer Center, Myrtle Beach

38119

Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group, Memphis

63301

Missouri Cancer Care, P.C., Saint Charles

91767

ION/Pharmatech Network, Pomona

92270

Cancer and Blood Institute of the Desert, Rancho Mirage

Sponsors
All Listed Sponsors
lead

Pharmatech Oncology

INDUSTRY

NCT00026429 - Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter